Mohamad Makhzoumi's Net Worth

$166 Thousand

Who is Mohamad Makhzoumi?

Mohamad Makhzoumi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcellx, Inc., Berkshire Grey, Inc., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Senti Biosciences, Inc.\, Desktop Metal, Inc., Robinhood Markets, Inc., Nkarta, Inc., NeueHealth, Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., AVEO PHARMACEUTICALS INC, Mirum Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Annexon, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., Achaogen Inc, and Korro Bio, Inc..

SEC CIK

Mohamad Makhzoumi's CIK is 0001630226

Past Insider Trading and Trends

2022 was Mohamad Makhzoumi's most active year for acquiring shares with 6 total transactions. Mohamad Makhzoumi's most active month to acquire stocks was the month of April. 2021 was Mohamad Makhzoumi's most active year for disposing of shares, totalling 1 transactions. Mohamad Makhzoumi's most active month to dispose stocks was the month of April. 2023 saw Mohamad Makhzoumi paying a total of $0.00 for 475,543 shares, this is the most they've acquired in one year. In 2021 Mohamad Makhzoumi cashed out on 283 shares for a total of $9,172.03, their largest year based on trade value.